Women's Health

>

Latest News

The Most Common Bleeding Disorder in your Patients Could be Hiding in Plain Sight / image credit Charles Nakar, MD, courtesy of Indiana Hemophilia & Thrombosis Center
The Most Common Bleeding Disorder in Your Patients Could be Hiding in Plain Sight

November 5th 2024

von Willebrand disease affects up to 1% of the population yet diagnosis is delayed an average of 16 years after onset of symptoms, especially in women.

FDA Approves New Treatment for Uncomplicated UTIs: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves New Treatment for Uncomplicated UTIs: Daily Dose

November 4th 2024

GoodRx, Opill Team Up on OTC Delivery Program for Contraceptive / image credit ©Windy Night/stock adobe com
GoodRx, Opill Team Up on OTC Delivery Program for Contraceptive

November 2nd 2024

FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

October 25th 2024

FDA Updates Flublok Label with Safety Data for Pregnant Individuals / image credit pregnancy vaccination concept / ©Dmitry Naumov/stock.adobe.com
FDA Updates Flublok Label with Safety Data for Pregnant Individuals

October 23rd 2024

Latest CME Events & Activities

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

2024 Neuromuscular Summit

November 20, 2024

View More

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

May 3, 2025

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.